These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16596971

  • 1. The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.
    Bratcher NA, Farmer-Dougan V, Dougan JD, Heidenreich BA, Garris PA.
    J Exp Anal Behav; 2005 Nov; 84(3):371-99. PubMed ID: 16596971
    [Abstract] [Full Text] [Related]

  • 2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Nov; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 3. Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.
    Sotoyama H, Namba H, Takei N, Nawa H.
    Psychopharmacology (Berl); 2007 Apr; 191(3):783-92. PubMed ID: 17096084
    [Abstract] [Full Text] [Related]

  • 4. Dopamine receptors play distinct roles in sexual behavior expression of rats with a different sexual motivational tone.
    Guadarrama-Bazante IL, Canseco-Alba A, Rodríguez-Manzo G.
    Behav Pharmacol; 2014 Oct; 25(7):684-94. PubMed ID: 25171081
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
    Chiang FK, Cheng RK, Liao RM.
    Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855
    [Abstract] [Full Text] [Related]

  • 6. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 7. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 8. Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats.
    Hoffman DC, Beninger RJ.
    Pharmacol Biochem Behav; 1989 Dec; 34(4):923-5. PubMed ID: 2576145
    [Abstract] [Full Text] [Related]

  • 9. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA, Pokora MJ, Widzowski DV.
    Brain Res; 1992 Dec 11; 598(1-2):162-72. PubMed ID: 1362517
    [Abstract] [Full Text] [Related]

  • 10. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
    Pinna A, Di Chiara G.
    Behav Pharmacol; 1998 Feb 11; 9(1):15-21. PubMed ID: 9832944
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C, Chase TN.
    Eur J Pharmacol; 1993 Feb 09; 231(2):191-6. PubMed ID: 8095897
    [Abstract] [Full Text] [Related]

  • 12. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE, Holtzman SG.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):65-75. PubMed ID: 7813580
    [Abstract] [Full Text] [Related]

  • 13. Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats.
    Guo M, Xiang T, Li M, Sun Y, Sun S, Chen D, Jia Q, Li Y, Yao X, Wang X, Zhang X, He F, Wang M.
    Behav Brain Res; 2021 Aug 06; 411():113339. PubMed ID: 33945831
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K, Smith SE, Sharp T.
    J Psychopharmacol; 1998 Aug 06; 12(3):252-7. PubMed ID: 10958251
    [Abstract] [Full Text] [Related]

  • 15. Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement.
    Wolterink G, Phillips G, Cador M, Donselaar-Wolterink I, Robbins TW, Everitt BJ.
    Psychopharmacology (Berl); 1993 Aug 06; 110(3):355-64. PubMed ID: 7831431
    [Abstract] [Full Text] [Related]

  • 16. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1996 Apr 06; 124(3):231-40. PubMed ID: 8740044
    [Abstract] [Full Text] [Related]

  • 17. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 06; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 18. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep 06; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 19. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
    Hooks MS, Jones DN, Holtzman SG, Juncos JL, Kalivas PW, Justice JB.
    Psychopharmacology (Berl); 1994 Oct 06; 116(2):217-25. PubMed ID: 7862951
    [Abstract] [Full Text] [Related]

  • 20. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL, Allen JD.
    Pharmacol Biochem Behav; 1996 Apr 06; 53(4):759-64. PubMed ID: 8801575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.